map

I scout for hidden clues that offer promise or warning for a stock and post on twitter. Mostly biotech.

[map @Bio_Scout]

$RGNX @REGENXBIO $ABBV Presentation on bilateral subretinal gene therapy of RGX-314 (Sura-Vec) presented at CTS Retina this weekend.

Confirmed by Dr. Arshad Khanani at 2:16: https://t.co/z5gxMZoKsP

[map @Bio_Scout]

$RGNX @REGENXBIO High profile investigational trial site Bay Area Retina added the RGX-314 trial for DR via SCS (although not listed yet on the https://t.co/fRMiZ5biAp site yet). Check out the minutes for the approval of the trial, dated end of April: https://t.co/dW3sY9NP00

[map @Bio_Scout]

$RGNX @REGENXBIO Next week RGNX PR for the DR PH2/b is tee'd up to complement the CTS Retina conference next weekend.

Regenxbio is doing a 3-hour education for top ophthalmologists on the new DR trial.

$100,000,000 and high visibility...make some noise next Wed. $ABBV at GS.

[map @Bio_Scout]

$RGNX @REGENXBIO Positive comments re: gene therapy per EveryLife Foundation:

FDA re: rare disease would be a top priority.

importance of regulatory flexibility was stressed

leadership does not appear hostile to accelerated approval

Read here:

https://t.co/RV3beFeyL2

[map @Bio_Scout]

@k_jhp https://t.co/HfPrgEPlnv

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

@blvckstance https://t.co/HfPrgEPlnv

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

@Hunter_Dolshun https://t.co/HfPrgEPlnv

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

@tyler_jordynE https://t.co/HfPrgEPlnv

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

@Leticia21441931 https://t.co/HfPrgEPlnv

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

@k_jhp https://t.co/HfPrgEPlnv

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

$RGNX @REGENXBIO New DR clinical site added today. Let's get the PR of first patient dosed!

https://t.co/wFOlN8yKfq

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

$RGNX @REGENXBIO Regenxbio providing a 3-hour training for ophthalmologists on June 12th for the new PH2B DR trial coordinated with Clinical Trials at the Summit a high-level conference. See my stocktwit post for more details.

https://t.co/4gsldcbOLK

https://t.co/PqhRU5fUxl

[map @Bio_Scout]

$RGNX @REGENXBIO New job position just filled:

(Sr.) Director, GCP & GLP QA

Regenxbio is beefing up high level positions.

[map @Bio_Scout]

$RGNX @REGENXBIO $ABBV The upcoming PR to release the $100,000,000 may also state:

"global development progressing rapidly"
"expanded collaboration on new molecules"
"accelerated enrollment plans"
"physician enthusiasm is high"

Coming soon!!!

[map @Bio_Scout]

@elonmusk Elon, please get one of your tech people to clean up the crypto spam that infiltrates the stock message boards, it makes these boards useless to investors. Please start at RGNX.

[map @Bio_Scout]

$RGNX @REGENXBIO Reposting relevant info above all the crypto spam junk that X allows to infiltrate stock message boards.

[map @Bio_Scout]

$RGNX @REGENXBIO Stifel: PT $42 BUY Rating

https://t.co/zAtVAj6LxT

[map @Bio_Scout]

$RGNX @REGENXBIO Stifel: PT $42 BUY Rating

https://t.co/zAtVAj6LxT

[map @Bio_Scout]

$RGNX @REGENXBIO New May slide deck up:

https://t.co/syGPzF4Q5q

[map @Bio_Scout]

@T697029T @TraderNorway @Scooter0732 2H26

[map @Bio_Scout]

@DeepSouthDoctor respect your thoughts...why not hold RGNX through the 1 patient dosed for DR and $100 million milestone from ABBV? ETA is 1H26.